Faster and safer safety cabinet fumigation

Published: 18-Feb-2011
Containment Manufacturing Ingredients Regulatory Cleaning

Hydrogen peroxide system offers alternative to toxic formaldehyde fumigation of safety cabinets

New from isolator producer Skan AG is the Skanair DECOSIS fumigation system, which eliminates biosafety risks prior to the maintenance of microbiological safety cabinets and other biocontainment units.

An easier and faster alternative to formaldehyde fumigation, the Skanair DECOSIS is a mobile unit used directly in the lab, and connected to the safety cabinet via two tubes. It functions autonomously thanks to a control system and catalytic converter.

Because it uses hydrogen peroxide (H2O2) as a biocide, decomposition products are unproblematic, and maintenance work can subsequently be safely carried out on the decontaminated cabinet.

The unit can be used to decontaminate microbiological safety cabinets in advance of maintenance work, when changing job or location, in preparation for disposal, or in the event of breakdowns or accidents.

It can also be used to decontaminate incubators, air locks and small isolators.

The cabinet continues to run in reduced mode throughout the procedure. The trained maintenance technician enters the corresponding facility parameters at a control system display, together with the quantity of H2O2 defined on the basis of the Skanair DECOSIS validation.

The process starts at the touch of a button, and runs completely automatically: the internal ventilation unit maintains slight negative pressure and feeds H2O2 vapour through the front cover into the cabinet, continuously circulating it inside the cabinet to reach all contaminated areas. The exhaust air through the cabinet‘s HEPA filter is then fed back into the Skanair DECOSIS via the second tube to be recirculated.

The decontamination phase is followed by the flushing phase: any biocides in the exhaust air from the cabinet are removed inside the Skanair DECOSIS via a catalytic converter and a final HEPA filter. This air can then be released directly into the lab, without having to be extracted via the building exhaust air system.

See more

You may also like

Containment

Ajinomoto Bio-Pharma Services expands fill-finish with new suite

Read more
The biopharma CDMO has announced it will soon open a high-speed multi-purpose fill-finish line in its commercial manufacturing facility located in San Diego, CA

Trending Articles

  1. Adragos Pharma acquires Sanofi's Maisons-Alfort sterile fill-finish facility to strengthen European injectables network Global CDMO Adragos Pharma has completed the acquisition of one of Europe's largest sterile injectables manufacturing sites from Sanofi in Maisons-Alfort, France, adding high-volume pre-filled syringe capabilities to its existing fill-finish operations in Switzerland and Livron
  2. Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
  3. FDA approves Lilly's oral GLP-1 pill Foundayo for obesity with no food or water restrictions Eli Lilly has received FDA approval for Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight that requires no fasting or water restrictions, with clinical trial participants on the highest dose losing an average of 27 pounds
  4. Marchesini Group at Interpack 2026 Sustainability, primary packaging, aseptic production, robotics and digital innovation at the heart of this edition
  5. L.B. Bohle hosts successful continuous manufacturing workshop in Brazil Focus on continuous wet granulation and drying for research, development and small-scale production

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Containment

Ajinomoto Bio-Pharma Services expands fill-finish with new suite

The biopharma CDMO has announced it will soon open a high-speed multi-purpose fill-finish line in its commercial manufacturing facility located in San Diego, CA
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Accelerating the development of bispecific antibodies

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Regulatory

UK REACH ATRm: CBA welcomes progress but warns of significant hurdles ahead

The Chemical Business Association has acknowledged long-awaited movement on the UK REACH Alternative Transitional Registration model following DEFRA's consultation response, but cautioned that cost burdens likely running into hundreds of millions of pounds
Manufacturing

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
Regulatory

Lonza Nominates Stephen Fry as Independent Board Member

Basel, Switzerland, 31 March 2026 – The Lonza Board of Directors today announced the nomination of Stephen Fry as an Independent Member of the Board. Subject to his election at the Lonza Group Annual General Meeting (AGM) in May 2026, Stephen will also be appointed a member of the People and Governance Committee and the Audit and Compliance Committeex
Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Subscribe now